Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Grinding of nano-graphite inkjet inks for application in organic solar cells.

Nanotechnology

Kastner J, Gnatiuk I, Wagner M, Holzinger D, Rudelstorfer V, Hesser G, Fuchsbauer A, Hild S.
PMID: 30465544
Nanotechnology. 2019 Jan 25;30(4):045601. doi: 10.1088/1361-6528/aae67a. Epub 2018 Nov 22.

The production of printable graphene flakes is not easy to scale up when produced by ultrasonication and purified by centrifugation. In this work, natural graphite flakes were exfoliated by wet ball milling in water supported by the addition of...

Cite
Kastner J, Gnatiuk I, Wagner M, et al. Grinding of nano-graphite inkjet inks for application in organic solar cells. Nanotechnology. 2018;30(4):045601doi: 10.1088/1361-6528/aae67a.
Kastner, J., Gnatiuk, I., Wagner, M., Holzinger, D., Rudelstorfer, V., Hesser, G., Fuchsbauer, A., & Hild, S. (2019). Grinding of nano-graphite inkjet inks for application in organic solar cells. Nanotechnology, 30(4), 045601. https://doi.org/10.1088/1361-6528/aae67a
Kastner, Julia, et al. "Grinding of nano-graphite inkjet inks for application in organic solar cells." Nanotechnology vol. 30,4 (2019): 045601. doi: https://doi.org/10.1088/1361-6528/aae67a
Kastner J, Gnatiuk I, Wagner M, Holzinger D, Rudelstorfer V, Hesser G, Fuchsbauer A, Hild S. Grinding of nano-graphite inkjet inks for application in organic solar cells. Nanotechnology. 2019 Jan 25;30(4):045601. doi: 10.1088/1361-6528/aae67a. Epub 2018 Nov 22. PMID: 30465544.
Copy Download .nbib Format: NLM
Crestal Sinus Augmentation with Recombinant Human Bone Morphogenetic Protein 2: Clinical and Radiographic Outcomes of 2-Year Pilot Trial.

The International journal of oral & maxillofacial implants

Kuchler U, Rudelstorfer CM, Barth B, Tepper G, Lidinsky D, Heimel P, Watzek G, Gruber R.
PMID: 28618433
Int J Oral Maxillofac Implants. 2017 July/August;32(4):e213–e220. doi: 10.11607/jomi.5536. Epub 2017 Jun 14.

PURPOSE: Recombinant human bone morphogenetic protein 2 (rhBMP-2) together with an absorbable collagen carrier (ACS) was approved for augmentation of the maxillary sinus prior to implant placement. The original registration trial was based on a lateral window approach. Clinical...

Cite
Kuchler U, Rudelstorfer CM, Barth B, et al. Crestal Sinus Augmentation with Recombinant Human Bone Morphogenetic Protein 2: Clinical and Radiographic Outcomes of 2-Year Pilot Trial. Int J Oral Maxillofac Implants. 2017;32(4):e213–e220doi: 10.11607/jomi.5536.
Kuchler, U., Rudelstorfer, C. M., Barth, B., Tepper, G., Lidinsky, D., Heimel, P., Watzek, G., & Gruber, R. (2017). Crestal Sinus Augmentation with Recombinant Human Bone Morphogenetic Protein 2: Clinical and Radiographic Outcomes of 2-Year Pilot Trial. The International journal of oral & maxillofacial implants, 32(4), e213–e220. https://doi.org/10.11607/jomi.5536
Kuchler, Ulrike, et al. "Crestal Sinus Augmentation with Recombinant Human Bone Morphogenetic Protein 2: Clinical and Radiographic Outcomes of 2-Year Pilot Trial." The International journal of oral & maxillofacial implants vol. 32,4 (2017): e213–e220. doi: https://doi.org/10.11607/jomi.5536
Kuchler U, Rudelstorfer CM, Barth B, Tepper G, Lidinsky D, Heimel P, Watzek G, Gruber R. Crestal Sinus Augmentation with Recombinant Human Bone Morphogenetic Protein 2: Clinical and Radiographic Outcomes of 2-Year Pilot Trial. Int J Oral Maxillofac Implants. 2017 July/August;32(4):e213–e220. doi: 10.11607/jomi.5536. Epub 2017 Jun 14. PMID: 28618433.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries